Dutch Appellate Court Upholds Lipitor Patent

Law360, New York (February 21, 2008, 12:00 AM EST) -- An appellate court in the Netherlands has upheld a patent covering a key component of Pfizer Inc.’s blockbuster cholesterol drug Lipitor, the pharmaceutical company said Thursday.

The decision by the Court of Appeal of The Hague in the Netherlands will delay the launch of a generic version of Lipitor by Indian generic maker Ranbaxy Laboratories Ltd. until Pfizer’s patent expires in November 2011.

Pfizer said the patent, EP 247,633, is a basic patent covering atorvastatin, the active ingredient in Lipitor.

“Today’s decision is another affirmation of...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.